157 related articles for article (PubMed ID: 6344327)
1. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
[TBL] [Abstract][Full Text] [Related]
2. Gastric inhibitory polypeptide (GIP) in maturity-onset diabetes mellitus.
Crockett SE; Mazzaferri EL; Cataland S
Diabetes; 1976 Oct; 25(10):931-5. PubMed ID: 976601
[TBL] [Abstract][Full Text] [Related]
3. Hypersecretion of gastric inhibitory polypeptide following oral glucose in diabetes mellitus.
Ross SA; Brown JC; Dupré J
Diabetes; 1977 Jun; 26(6):525-9. PubMed ID: 324834
[TBL] [Abstract][Full Text] [Related]
4. Gastric inhibitory polypeptide response to hyper- and hypoglycemia in insulin-dependent diabetics.
Reynolds C; Tronsgard N; Gibbons E; Blix PM; Rubenstein AH
J Clin Endocrinol Metab; 1979 Aug; 49(2):255-61. PubMed ID: 457845
[TBL] [Abstract][Full Text] [Related]
5. Gastric inhibitory polypeptide responses to nutrients in Caucasians and American Indians with obesity and noninsulin-dependent diabetes mellitus.
Mazzaferri EL; Starich GH; Lardinois CK; Bowen GD
J Clin Endocrinol Metab; 1985 Aug; 61(2):313-21. PubMed ID: 4008608
[TBL] [Abstract][Full Text] [Related]
6. Effects of ingestion of triglyceride or galactose on secretion of gastric inhibitory polypeptide and on responses to intravenous glucose in normal and diabetic subjects.
Ross SA; Dupre J
Diabetes; 1978 Mar; 27(3):327-33. PubMed ID: 640238
[TBL] [Abstract][Full Text] [Related]
7. Hypersecretion of gastric inhibitory polypeptide induced by glucose ingestion in diabetes mellitus.
Takemura J; Seino Y; Tsuda K; Seino S; Ikeda M; Sakurai H; Imura H
Endocrinol Jpn; 1981 Feb; 28(1):17-21. PubMed ID: 7250066
[TBL] [Abstract][Full Text] [Related]
8. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
Lauritsen KB; Moody AJ
Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
[TBL] [Abstract][Full Text] [Related]
9. Gastric inhibitory polypeptide hypersecretion in diabetes mellitus: effect of sulfonylurea treatment.
Coxe JS; O'Dorisio TM; Cataland S; Crockett SE
J Clin Endocrinol Metab; 1981 May; 52(5):1002-5. PubMed ID: 7014585
[TBL] [Abstract][Full Text] [Related]
10. Gastric inhibitory polypeptide release after oral glucose: relationship to glucose intolerance, diabetes mellitus, and obesity.
Salera M; Giacomoni P; Pironi L; Cornia G; Capelli M; Marini A; Benfenati F; Miglioli M; Barbara L
J Clin Endocrinol Metab; 1982 Aug; 55(2):329-36. PubMed ID: 7045154
[TBL] [Abstract][Full Text] [Related]
11. Impaired feedback control of fat induced gastric inhibitory polypeptide (GIP) secretion by insulin in obesity and glucose intolerance.
Ebert R; Frerichs H; Creutzfeldt W
Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):129-35. PubMed ID: 111943
[TBL] [Abstract][Full Text] [Related]
12. Gastric inhibitory polypeptide and insulin: response to intraduodenal and intravenous glucose infusions in fetal and neonatal pigs.
Kühl C; Hornnes PJ; Jensen SL; Lauritsen KB
Endocrinology; 1980 Nov; 107(5):1446-50. PubMed ID: 7000494
[TBL] [Abstract][Full Text] [Related]
13. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
[TBL] [Abstract][Full Text] [Related]
14. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
[TBL] [Abstract][Full Text] [Related]
15. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
McCullough AJ; Miller LJ; Service FJ; Go VL
J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
[TBL] [Abstract][Full Text] [Related]
16. The association between plasma GIP and insulin after oral glucose.
Lauritsen KB; Moody AJ
Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
[TBL] [Abstract][Full Text] [Related]
17. Glucose-induced GIP levels in patients with insulinoma.
Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
[TBL] [Abstract][Full Text] [Related]
18. The enteric enhancement of glucose-stimulated insulin release. The role of GIP in aging, obesity, and non-insulin-dependent diabetes mellitus.
Elahi D; Andersen DK; Muller DC; Tobin JD; Brown JC; Andres R
Diabetes; 1984 Oct; 33(10):950-7. PubMed ID: 6383904
[TBL] [Abstract][Full Text] [Related]
19. Diminished immunoreactive gastric inhibitory polypeptide response to a meal in newly diagnosed type I (insulin-dependent) diabetics.
Krarup T; Madsbad S; Moody AJ; Regeur L; Faber OK; Holst JJ; Sestoft L
J Clin Endocrinol Metab; 1983 Jun; 56(6):1306-12. PubMed ID: 6341393
[TBL] [Abstract][Full Text] [Related]
20. Discrepant performance on oral and intravenous glucose tolerance tests: the role of gastric inhibitory polypeptide.
Elahi D; Andersen DK; Tobin JD; Andres R
J Clin Endocrinol Metab; 1981 Jun; 52(6):1199-203. PubMed ID: 7014599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
